[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351984-105":59,"doc-detail-351984-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","clinicopathological-features-of-breast-cancer-in-ukrainian-women-with-brca1-c181tg-p-cys61gly-variant-a-case-series","Clinicopathological features of breast cancer in Ukrainian women with BRCA1 c.181T>G (p. Cys61Gly) variant - a case series","","BRCA1 c.181T>G (p.Cys61Gly) is a pathogenic founder variant with limited Ukrainian clinical evidence. This single-centre case series characterizes clinical presentation, tumor biology, and family history in women with primary breast cancer and/or ovarian cancer carrying the BRCA1 c.181T>G variant. Thirteen patients showed early-onset breast cancer dominance, frequent multiple malignancies, and strong familial clustering, with heterogeneous biomarker patterns and invasive nodal involvement in many cases. Findings support expanded genetic testing and tailored surveillance in Ukraine’s founder-variant landscape.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/clinicopathological-features-of-breast-cancer-in-ukrainian-women-with-brca1-c181tg-p-cys61gly-variant-a-case-series/351984/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/clinicopathological-features-of-breast-cancer-in-ukrainian-women-with-brca1-c181tg-p-cys61gly-variant-a-case-series/351984.png","ImageObject",300,407,{"name":92,"@type":93},"Anna Hans","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main objective of the study?","Question",{"text":113,"@type":114},"To characterize clinical presentation, tumor biology, and family history in Ukrainian women with the BRCA1 c.181T>G variant.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What patient and disease types were included?",{"text":118,"@type":114},"Women with primary breast cancer and/or ovarian cancer carrying the BRCA1 c.181T>G variant, treated at a single Ukrainian oncology center between January 2024 and August 2025.",{"name":120,"@type":111,"acceptedAnswer":121},"What key clinicopathological patterns were reported?",{"text":122,"@type":114},"Early-onset breast cancer was common, multiple malignancies occurred in many patients, biomarker profiles varied (including luminal-like and triple-negative cases), and more than half showed positive nodal status.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},351984,1790492598,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":46,"preview_page_count":19,"preview_urls":145},5909892332657,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","TYPE Original Research PUBLISHED 30 June 2026  \nDOI 10.3389/fendo.2026.1859939  \nOPEN ACCESS  \nEDITED BY  \nVijaya Kumar Pidugu,  \nCenter for Cancer Research, National Cancer Institute, United States  \nREVIEWED BY  \nHira Bani Hani,  \nKing Hussein Cancer Center, Jordan Weikai Xiao,  \nGuangdong Second Provincial General Hospital, China  \n*CORRESPONDENCE  \nNazarii Kobyliak  \n [nazariikobyliak@gmail.com](nazariikobyliak@gmail.com)[ ](nazariikobyliak@gmail.com)Oksana Sulaieva  \n [o.sulaieva@csd.com.ua](o.sulaieva@csd.com.ua)[ ](o.sulaieva@csd.com.ua)RECEIVED 19 April 2026 REVISED 15 June 2026 ACCEPTED 15 June 2026 PUBLISHED 30 June 2026  \nCITATION  \nKitsera N, Shparyk Y, Tril O, Protsko I, Duda I, Oleksyak O, Hrynkiv A, Dovhanyk I, Hrytsai I, Tril I, Makukh H, Kruhlykova A, Kozakov D, Livshun S, Kobyliak N, Sobechko S, Oliyarnyk M and Sulaieva O (2026) Clinicopathological features of breast cancer in Ukrainian women with BRCA1 c.181T>G (p. Cys61Gly) variant: a case series.  \nFront. Endocrinol. 17:1859939 .  \ndoi: 10.3389/fendo.2026.1859939  \nCOPYRIGHT  \n© 2026 Kitsera, Shparyk, Tril, Protsko, Duda, Oleksyak, Hrynkiv, Dovhanyk, Hrytsai, Tril, Makukh, Kruhlykova, Kozakov, Livshun, Kobyliak, Sobechko, Oliyarnyk and Sulaieva. This is an open-access article distributed under the terms of the  \nCreative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nClinicopathological features of breast cancer in Ukrainian women with BRCA1 c.181T>G (p.Cys61Gly) variant: a case series  \nNataliya Kitsera 1,2, Yaroslav Shparyk1, Orest Tril 1, Ihor Protsko 1, Ivanna Duda 1, Olha Oleksyak 1, Andrii Hrynkiv 1, Irena Dovhanyk 1, Iryna Hrytsai 1, Iryna Tril 1, Halyna Makukh 3, Alina Kruhlykova 4,5, Denys Kozakov 4,6, Soﬁia Livshun 4,6, Nazarii Kobyliak 4,7*, Solomiia Sobechko 3, Myroslava Oliyarnyk 1  \nand Oksana Sulaieva 4,5,7*  \n1 Lviv Oncologic Regional Treatment and Diagnostic Center, Lviv, Ukraine, 2 Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine, 3Scientiﬁc and Medical Genetic Center “LeoGENE”, Lviv, Ukraine, 4 Medical laboratory CSD, Kyiv, Ukraine, 5 Ukrainian Association for Precision Medicine, Kyiv, Ukraine, 6 Institute of Molecular Biology and Genetics National Academy of Sciences (NAS) of Ukraine, Kyiv, Ukraine, 7 Bogomolets National Medical University, Kyiv, Ukraine  \nIntroduction: BRCA1 c.181T>G (p.Cys61Gly) is a pathogenic founder genetic variant prevalent in Central and Eastern Europe. The data on its clinicopathological manifestations in Ukrainian patients remain limited.  \nAim: This study aimed to characterize clinical presentation, tumor biology, and family history in Ukrainian women with BRCA1 c. 181T>G variant.  \nMaterials and methods: We conducted a single-centre case series of women with primary breast cancer (BC) and/or ovarian cancer (OC) harbouring BRCA1 c.181T>G genetic variant and treated at Lviv Regional Oncology Treatment and Diagnostic Center (Ukraine) between January 2024 and August 2025 . Clinical presentation, tumor pathology, biomarker status, family history, treatment, and outcomes were analysed.  \nResults: Thirteen women aged 29–81 years (median 35 years) were included in this case series. Early-onset BC was recorded in 10 (76 . 9%) of patients diagnosed before 40 years. BC was the initial malignancy in 12 (92 .3%) patients. OC occurred as a ﬁrst tumor in 1 (7 .7%) and as a subsequent cancer in 4 (30 . 8%) patients. Multiple malignancies were observed in 61.5% of patients, with intervals of 5–21 years between diagnoses. Family history revealed strong clustering of BC and OC across generations, often involving multiple affected relatives, consistent with hereditary breast and ovari","cbCaiqA8Swz3imsl","https://ap.wps.com/l/cbCaiqA8Swz3imsl","pdf",710474,"English","# Introduction\n# Aim\n# Materials and methods\n# Results\n# Conclusions","[{\"question\":\"What is the main objective of the study?\",\"answer\":\"To characterize clinical presentation, tumor biology, and family history in Ukrainian women with the BRCA1 c.181T\\u003eG variant.\"},{\"question\":\"What patient and disease types were included?\",\"answer\":\"Women with primary breast cancer and/or ovarian cancer carrying the BRCA1 c.181T\\u003eG variant, treated at a single Ukrainian oncology center between January 2024 and August 2025.\"},{\"question\":\"What key clinicopathological patterns were reported?\",\"answer\":\"Early-onset breast cancer was common, multiple malignancies occurred in many patients, biomarker profiles varied (including luminal-like and triple-negative cases), and more than half showed positive nodal status.\"}]","Clinicopathological features of breast cancer in Ukrainian women with BRCA1 c.181T>G (p. Cys61Gly) variant - a case series | PDF",1790096677,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/040aec813dca5e6ea460c1f7ab7e4700.webp",983,1389,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2acb59101f3f00db8fb96380aed7f26c.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/01a66a32d883558e9ace2cb9cb30b4d0.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f3283cad41fbe2d5798de8a5ffbe6025.webp",980,1385]